Your browser doesn't support javascript.
loading
A broadly cross-reactive monoclonal antibody against hepatitis E virus capsid antigen.
Kubickova, Barbara; Schenk, Jörg A; Ramm, Franziska; Markuskiene, Kornelija; Reetz, Jochen; Dremsek, Paul; Tamosiunas, Paulius Lukas; Cepulyte, Laima; Trinh, Hoai Anh; Scholz, Johannes; Memczak, Henry; Hovestädt, Marc; Ryll, René; Petraityte-Burneikiene, Rasa; Corman, Victor M; Andersson, Anika; Becher, Dietmar; Groschup, Martin H; Kubick, Stefan; Sellrie, Frank; Johne, Reimar; Ulrich, Rainer G.
Affiliation
  • Kubickova B; Institute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, 17493, Greifswald-Insel Riems, Germany.
  • Schenk JA; RECETOX, Faculty of Science, Masaryk University, 62500, Brno, Czech Republic.
  • Ramm F; Hybrotec GmbH, 14476, Potsdam, Germany.
  • Markuskiene K; UP Transfer GmbH an der Universität Potsdam, 14469, Potsdam, Germany.
  • Reetz J; Branch Bioanalytics and Bioprocesses (IZI-BB), Fraunhofer Institute for Cell Therapy and Immunology (IZI), 14476, Potsdam, Germany.
  • Dremsek P; Institute of Chemistry and Biochemistry, Freie Universität Berlin, 14195, Berlin, Germany.
  • Tamosiunas PL; Institute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, 17493, Greifswald-Insel Riems, Germany.
  • Cepulyte L; Institute of Biotechnology, Life Sciences Centre, Vilnius University, 02241, Vilnius, Lithuania.
  • Trinh HA; German Federal Institute for Risk Assessment, 10589, Berlin, Germany.
  • Scholz J; Institute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, 17493, Greifswald-Insel Riems, Germany.
  • Memczak H; Zentrum für Pathobiochemie und Genetik, Medizinische Universität Wien, 1090, Wien, Austria.
  • Hovestädt M; Institute of Biotechnology, Life Sciences Centre, Vilnius University, 02241, Vilnius, Lithuania.
  • Ryll R; Institute of Biotechnology, Life Sciences Centre, Vilnius University, 02241, Vilnius, Lithuania.
  • Petraityte-Burneikiene R; Branch Bioanalytics and Bioprocesses (IZI-BB), Fraunhofer Institute for Cell Therapy and Immunology (IZI), 14476, Potsdam, Germany.
  • Corman VM; German Federal Institute for Risk Assessment, 10589, Berlin, Germany.
  • Andersson A; qpa bioanalytics GmbH, 10585, Berlin, Germany.
  • Becher D; qpa bioanalytics GmbH, 10585, Berlin, Germany.
  • Groschup MH; Surflay Nanotec, 12489, Berlin, Germany.
  • Kubick S; Institute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, 17493, Greifswald-Insel Riems, Germany.
  • Sellrie F; Institute of Biotechnology, Life Sciences Centre, Vilnius University, 02241, Vilnius, Lithuania.
  • Johne R; Institute of Virology, Charité - Universitätsmedizin Berlin, 10117, Berlin, Germany.
  • Ulrich RG; Site Berlin, German Center for Infection Research (DZIF), 10117, Berlin, Germany.
Appl Microbiol Biotechnol ; 105(12): 4957-4973, 2021 Jun.
Article de En | MEDLINE | ID: mdl-34129082
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Virus de l'hépatite E Limites: Animals / Humans Langue: En Journal: Appl Microbiol Biotechnol Année: 2021 Type de document: Article Pays d'affiliation: Allemagne
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Virus de l'hépatite E Limites: Animals / Humans Langue: En Journal: Appl Microbiol Biotechnol Année: 2021 Type de document: Article Pays d'affiliation: Allemagne